Search
Protagonist Therapeutics Inc
PTGXAdd to Watchlist
112.180USD
+0.740+0.66%
Market hours （ET）Quotes delayed by 15 min
7.20BMarket Cap
LossP/E TTM
Protagonist Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-17The current valuation score of Protagonist Therapeutics Inc is 9.48, ranking 31 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -61.77, which is -298.75% below the recent high of 122.78 and -0.92% above the recent low of -62.34.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
